Detalles de la búsqueda
1.
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis.
N Engl J Med
; 2024 Jun 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38847460
2.
Efficacy, tolerability and pharmacokinetics of survodutide, a glucagon/glucagon-like peptide-1 receptor dual agonist, in cirrhosis.
J Hepatol
; 2024 Jun 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38857788
3.
Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER®, RE-COVER™ II, and RE-MEDY™.
Vasc Med
; 21(6): 506-514, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27807306
4.
Management and outcomes of major bleeding during treatment with dabigatran or warfarin.
Circulation
; 128(21): 2325-32, 2013 Nov 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-24081972
5.
Response to letter regarding article, "Management and outcomes of major bleeding during treatment with dabigatran or warfarin".
Circulation
; 130(10): e95, 2014 Sep 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-25210103
6.
Rationale, design, and protocol of a randomized controlled trial of the safety and efficacy of dabigatran etexilate versus dose-adjusted warfarin in patients with cerebral venous thrombosis.
Int J Stroke
; 13(7): 766-770, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29775170
7.
Concomitant Oral Anticoagulant and Nonsteroidal Anti-Inflammatory Drug Therapy in Patients With Atrial Fibrillation.
J Am Coll Cardiol
; 72(3): 255-267, 2018 07 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-30012318
8.
Dabigatran versus Warfarin for Acute Venous Thromboembolism in Elderly or Impaired Renal Function Patients: Pooled Analysis of RE-COVER and RE-COVER II.
Thromb Haemost
; 117(11): 2045-2052, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29202209
9.
Treatment of acute pulmonary embolism with dabigatran versus warfarin. A pooled analysis of data from RE-COVER and RE-COVER II.
Thromb Haemost
; 116(4): 714-21, 2016 Sep 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-27411591
10.
Urgent surgery or procedures in patients taking dabigatran or warfarin: Analysis of perioperative outcomes from the RE-LY trial.
Thromb Res
; 139: 77-81, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26916299
11.
Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial.
Thromb Haemost
; 113(3): 625-32, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25472710
12.
Cardiovascular outcomes during treatment with dabigatran: comprehensive analysis of individual subject data by treatment.
Vasc Health Risk Manag
; 9: 599-615, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24143109
13.
Dabigatran compared with warfarin in patients with atrial fibrillation and symptomatic heart failure: a subgroup analysis of the RE-LY trial.
Eur J Heart Fail
; 15(9): 1053-61, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23843099
14.
Efficacy and augmentation during 6 months of double-blind pramipexole for restless legs syndrome.
Sleep Med
; 12(4): 351-60, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21354368
Resultados
1 -
14
de 14
1
Próxima >
>>